A new study has found that reduced glutathione, when combined with entecavir, significantly improves liver function, reduces fibrosis, and enhances HBV-DNA clearance in chronic hepatitis B patients.
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of ...
Yesterday, Mindy Kaling received her star on the Hollywood Walk of Fame, and she was joined by a familiar face. Kicking off the ceremony, Mindy’s The Office costar, longtime friend, and ex B.J. Novak ...
3d
Zacks Small Cap Research on MSNINAB: Continued Survival in INB-100 TrialINAB READ THE FULL INAB RESEARCH REPORT IN8bio, Inc (NASDAQ:INAB) updates survival data for its INB-100 trial in a February ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...
13d
MyChesCo on MSNCSL Reports Promising Four-Year Data on Gene Therapy for Hemophilia BCSL (ASX: CSL; USOTC: CSLLY) has unveiled four-year results from its pivotal HOPE-B study, demonstrating the long-term ...
The Division of Hematology/Oncology provides a full range of inpatient and outpatient services for children and adolescents with malignancies and blood disorders. The Division of Pediatric ...
Hemlibra (emicizumab), a preventive treatment for hemophilia A, reduced pain and improved quality of life for adults and adolescents with the disease, including those with recurrent joint bleeds, a ...
I’ve heard it said by men of wide experience that podcasts used to be better in the old days. Kieran Healy discusses three short stories by Frank O’Connor: “First Confession,” “The Majesty of the Law, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results